|Articles|November 6, 2020
Assessing Multiple Critical Quality Attributes of Monoclonal Antibody and Comparability Assessments
Author(s)Agilent Technologies, Inc.
Discover how LC–MS peptide mapping can be used to characterize and quantify different monoclonal antibody (mAb) critical quality attributes (CQAs).
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Green Stabilizers in Nitrocellulose Propellants: VOC Fingerprinting of Accelerated Aging by HS-SPME–GC×GC–TOF-MS
2
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
3
Reactivating Your GPC/SEC Instrument After Shutdown
4
The Scientist’s Value in the Age of Automation
5
